Cargando…

Selection of a novel DNA aptamer against OFA/iLRP for targeted delivery of doxorubicin to AML cells

The standard treatment for most acute myeloid leukemia (AML) is chemotherapy, which is often associated with severe adverse effects. One strategy to reduce the adverse effects is targeted therapy that can selectively deliver anticancer drugs to tumor cells. Immature laminin receptor protein (OFA/iLR...

Descripción completa

Detalles Bibliográficos
Autores principales:	An, Yacong, Hu, Yan, Li, Xundou, Li, Zhaoyi, Duan, Jinhong, Yang, Xian-Da
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517398/ https://www.ncbi.nlm.nih.gov/pubmed/31089250 http://dx.doi.org/10.1038/s41598-019-43910-3

Ejemplares similares

Targeted Therapy of Colon Cancer by Aptamer-Guided Holliday Junctions Loaded with Doxorubicin
por: Yao, Fengjiao, et al.
Publicado: (2020)

Novel Bispecific Aptamer Enhances Immune Cytotoxicity Against MUC1-Positive Tumor Cells by MUC1-CD16 Dual Targeting
por: Li, Zhaoyi, et al.
Publicado: (2019)

Selection of a novel CD19 aptamer for targeted delivery of doxorubicin to lymphoma cells
por: Hu, Yan, et al.
Publicado: (2018)

Novel Complex of PD-L1 Aptamer and Albumin Enhances Antitumor Efficacy In Vivo
por: An, Yacong, et al.
Publicado: (2022)

Novel Complex of PD-L1 Aptamer and Holliday Junction Enhances Antitumor Efficacy in Vivo
por: Li, Ting, et al.
Publicado: (2021)

Targeted Treatment of Colon Cancer with Aptamer-Guided Albumin Nanoparticles Loaded with Docetaxel
por: Yu, Zhen, et al.
Publicado: (2020)

Novel Nanotherapeutics for Cancer Immunotherapy by PD-L1-Aptamer-Functionalized and Fexofenadine-Loaded Albumin Nanoparticles
por: Lai, Xialian, et al.
Publicado: (2023)

Investigating face-property specific processing in the right OFA
por: Kadosh, Kathrin Cohen, et al.
Publicado: (2011)

Direct primary care: Family physician perceptions of a growing model
por: Brekke, Gayle, et al.
Publicado: (2021)

Aptamer-Aptamer Chimera for Targeted Delivery and ATP-Responsive Release of Doxorubicin into Cancer Cells
por: Esawi, Ezaldeen, et al.
Publicado: (2021)

Aptamer–drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity
por: Dou, Xiao-qian, et al.
Publicado: (2018)

Aptamer-guided DNA tetrahedron as a novel targeted drug delivery system for MUC1-expressing breast cancer cells in vitro
por: Dai, Bindong, et al.
Publicado: (2016)

Selection of a Novel DNA Aptamer for Assay of Intracellular Interferon-Gamma
por: Cao, Beibei, et al.
Publicado: (2014)

Novel Aptamer-Nanoparticle Bioconjugates Enhances Delivery of Anticancer Drug to MUC1-Positive Cancer Cells In Vitro
por: Yu, Chenchen, et al.
Publicado: (2011)

Opioid-free anaesthesia (OFA) for elective cosmetic surgery: A role of processed EEG monitoring
por: Friedberg, Barry L.
Publicado: (2023)

Novel MUC1 Aptamer Selectively Delivers Cytotoxic Agent to Cancer Cells In Vitro
por: Hu, Yan, et al.
Publicado: (2012)

Occurrence Location and Propagation Inconformity Characteristics of Vibration Events in a Heading Face ofa Coal Mine
por: Ren, Jianju, et al.
Publicado: (2022)

Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery
por: Xiang, Dongxi, et al.
Publicado: (2017)

Application of an OFA strategy to ERAS in a 102-year-old patient undergoing colon cancer surgery: A case report
por: Dai, Jingwei, et al.
Publicado: (2023)

Effects of Parity and Serum Prolactin Levels on the Incidence and Regression of DMBA-Induced Tumors in OFA hr/hr Rats
por: Sasso, Corina V., et al.
Publicado: (2014)

Relationship between mortality risk and health-related factors and sense of coherence in residents ofa rural area in Japan
por: Yamauchi, Kanako, et al.
Publicado: (2020)

Inhibition of Autophagy Promotes the Elimination of Liver Cancer Stem Cells by CD133 Aptamer-Targeted Delivery of Doxorubicin
por: Yin, Wang, et al.
Publicado: (2022)

Targeted delivery of doxorubicin and therapeutic FOXM1 aptamer to tumor cells using gold nanoparticles modified with AS1411 and ATP aptamers
por: Abdollahzade, Aref, et al.
Publicado: (2023)

Aptamer Functionalized Upconversion Nanotheranostic Agent With Nuclear Targeting as the Highly Localized Drug-Delivery System of Doxorubicin
por: Song, Xinyue, et al.
Publicado: (2021)

Target-specific delivery of doxorubicin to retinoblastoma using epithelial cell adhesion molecule aptamer
por: Subramanian, Nithya, et al.
Publicado: (2012)

Calculations Pertaining to the Design ofa Prebuncher fora 150-MeV electron Linear Accelerator. 3. Comparisons with Experimental Data
por: Alsmiller, R G Jr, et al.
Publicado: (1985)

The effects of ultrasound-guided QLB and TAPB combined with opioid-free anesthesia (OFA) on clinical efficacy of the patients undergoing abdominal surgery
por: Dai, Jingwei, et al.
Publicado: (2023)

Doxorubicin Loaded DNA Aptamer Linked Myristilated Chitosan Nanogel for Targeted Drug Delivery to Prostate Cancer
por: Atabi, Fereshteh, et al.
Publicado: (2017)

Aptamer-functionalized Hybrid Nanoparticles to Enhance the Delivery of Doxorubicin into Breast Cancer Cells by Silencing P-glycoprotein
por: Chandra, Sruti, et al.
Publicado: (2020)

PrP(C) Aptamer Conjugated–Gold Nanoparticles for Targeted Delivery of Doxorubicin to Colorectal Cancer Cells
por: Go, Gyeongyun, et al.
Publicado: (2021)

Identification of familial colorectal cancer and hereditary colorectal cancer syndromes through the Dutch population-screening program: results ofa pilot study
por: van Erp, Sanne J. H., et al.
Publicado: (2016)

Mucin-1 aptamer-armed superparamagnetic iron oxide nanoparticles for targeted delivery of doxorubicin to breast cancer cells
por: Aghanejad, Ayuob, et al.
Publicado: (2018)

ssDNA Aptamer Specifically Targets and Selectively Delivers Cytotoxic Drug Doxorubicin to HepG2 Cells
por: Yu, Ge, et al.
Publicado: (2016)

Aptamers for Targeted Drug Delivery
por: Ray, Partha, et al.
Publicado: (2010)

Aptamer-targeted Antigen Delivery
por: Wengerter, Brian C, et al.
Publicado: (2014)

Characterisation of an aptamer against the Runt domain of AML1 (RUNX1) by NMR and mutational analyses
por: Takada, Kenta, et al.
Publicado: (2018)

Doxorubicin-Conjugated Innovative 16-mer DNA Aptamer-Based Annexin A1 Targeted Anti-Cancer Drug Delivery
por: Bavi, Rohit, et al.
Publicado: (2020)

Biocompatible Chitosan Nanobubbles for Ultrasound-Mediated Targeted Delivery of Doxorubicin
por: Zhou, Xiaoying, et al.
Publicado: (2019)

Nucleolin-Targeting AS1411 Aptamer-Modified Micelle for the Co-Delivery of Doxorubicin and miR-519c to Improve the Therapeutic Efficacy in Hepatocellular Carcinoma Treatment
por: Liang, Xiao, et al.
Publicado: (2021)

LRP5 and LRP6 in Wnt Signaling: Similarity and Divergence
por: Ren, Qian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_03qj6lehqi51kdibs8eok01taa